Learned eleven-gene melanoma score associates with survival in public expression cohorts
Source check: Source checked. Not independent scientific confirmation.
Finding: A penalized survival-model pipeline produced an eleven-gene melanoma score associated with observed survival in public expression cohorts. Model selection used both internal testing and an additional cohort, so the latter is not an untouched external test. The represented result is a retrospective prognostic association, without establishing novel cell types, causal tumor biology or improved treatment decisions.
Technology: Scissor phenotype-linked feature selection followed by LASSO Cox and ridge survival modeling
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- Phenotype-linked selection and penalized learned survival modeling combined expression measurements into the represented score, enabling observed survival stratification beyond generic clustering or pathway enrichment.
- Test and result
- The source linked single-cell data to bulk survival data using Scissor, derived prognosis-related gene sets and compared seventy-two model combinations. It selected a LASSO Cox/ridge eleven-gene score using average performance across testing datasets. The paper reports a survival-group association in GSE65904, described as 215 samples, with modest time-dependent discrimination.
- Limitation / still unknown
- Outcome-informed upstream filtering and use of testing cohorts to choose the final model compromise independent validation. The paper reports 469 available TCGA records but a different final subgroup count in discussion, without a reconstructed participant flow here. Reported survival-time labels differ between text and figure captions, so exact time-specific AUCs are not adopted. Single-cell cluster labels, including the claimed MITF-positive T-cell population, were not independently authenticated as new biological cell types. Many individual genes already have melanoma associations. No causal mechanism, treatment benefit or clinical decision utility was demonstrated.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://link.springer.com/article/10.1007/s12672-025-03701-x
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 21 Nov 2026. Review scope: Read actual clinical dataset, Scissor/feature/clustering and penalized model-selection Methods, final eleven-gene score and survival Results. Novel cell-type identity and causal biology are not adjudicated or admitted. Cohort-accounting and time-label inconsistencies are retained explicitly; no untouched external test claimed. Exact original article front DOI/title and fresh PubMed primary relationship metadata checked..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 1/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.